文献速递临床试验与 GCP医学教育与科研方法

八段锦运动对接受化疗的乳腺癌女性认知功能与生活质量影响的随机对照试验研究方案

Effect of Baduanjin exercise intervention on cognitive function and quality of life in women with breast cancer receiving chemotherapy: study protocol of a randomized controlled trial.
PubMed 文献 · Trials · 2021-06-19

本研究为单盲随机对照试验方案,拟从上海招募70例拟接受化疗的早期乳腺癌患者,按1:1随机分配至 supervised 八段锦组(每周5次、每次30分钟)或等待名单对照组,干预3个月。主要认知结局为FACT-Cog的PCI评分,于干预前、第8周和第12周评估主观与客观认知功能、疲劳、抑郁、焦虑及健康相关生活质量,采用意向性治疗原则和线性混合效应模型分析。

要点

  • 八段锦每周5次、每次30分钟、持续3个月,为监督下运动干预。
  • 主要认知结局为FACT-Cog的PCI评分,按描述性报告并计算效应量和95%CI。
  • 纳入70例早期乳腺癌化疗患者,单盲、1:1随机、等待名单对照。

核心结论

  • 该试验旨在评估八段锦运动对接受化疗的早期乳腺癌女性认知功能是否具有保护作用。
  • 若结果阳性,八段锦可能成为管理认知功能障碍的非药物干预手段。

研究设计与样本

  • 单盲随机对照试验,计划招募70例来自上海、拟接受化疗的早期乳腺癌患者。
  • 参与者按1:1随机分配至监督下八段锦组或等待名单对照组,干预3个月。
  • 评估时间点为干预前(T0)、第8周(T1)和第12周(T2)。

关键数值与推荐

  • 八段锦组干预频率为每周5次、每次30分钟,持续3个月。
  • 主要认知结局为FACT-Cog的PCI评分,采用描述性报告并计算效应量和95%CI。
  • 数据分析采用意向性治疗原则和线性混合效应模型。

临床怎么用

  • 八段锦作为潜在非药物干预,可能用于化疗乳腺癌患者的认知功能保护与症状管理。

局限性

  • 本文件为研究方案,尚未报告干预效果数据。
  • 样本量70例,为试点研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: More than 50% cognitive impairment was reported by cancer patients before and after medical treatment. However, there are no effective interventions to manage the cognitive problem in women with breast cancer. This pilot study was designed to evaluate the protective effect of Baduanjin exercise on cognitive function and cancer-related symptoms in women with early-stage breast cancer undergoing chemotherapy. METHOD: A single-blinded, randomized control trial was designed. The trial will recruit 70 patients with early-stage breast cancer scheduled to receive chemotherapy from Shanghai in China. All participants will be randomly assigned to (1:1) the supervised Baduanjin group (5 times/week, 30 min each time) or the wait-list control group for 3 months. The effect of Baduanjin exercise intervention will be evaluated by outcome measures including subjective and objective cognitive function, symptoms (fatigue, depression, and anxiety), and health-related quality of life at pre-intervention (T0), 8 weeks (T1), and 12 weeks (T2). The PCI score in the FACT-Cog as the primary cognitive outcome will be reported descriptively, while effect sizes and 95% confidence intervals (CIs) will be calculated. The collected data will be analyzed by using an intention-to-treat principle and linear mixed-effects modeling. DISCUSSION: This is the first randomized clinical trial to investigate whether Baduanjin exercise will have a positive role in improving cognitive function in women with breast cancer receiving chemotherapy. If possible, Baduanjin exercise will be a potential non-pharmacological intervention to manage cognitive dysfunction and promote survivorship care among breast cancer survivors. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR) ChiCTR2000033152 . Registered on 22 May 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wei XL, Yuan RZ, Jin YM, et al. Effect of Baduanjin exercise intervention on cognitive function and quality of life in women with breast cancer receiving chemotherapy: study protocol of a randomized controlled trial. Trials. 2021. PMID: 34147107. doi:10.1186/s13063-021-05355-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。